Description

The reference listed drugs selected by China National Medical Products Administration (NMPA) are reference products to which generic drugs should be equivalent in quality and therapeutic efficacy.

Related resource: Generic Drug Registration Application (ANDA) in China

6301 results
Export
Log in to view more data,
No. Drug Name Dosage Form Brand Name Strength MAH Note 1 Note 2 Batch
78-27   Risperdal Janssen Pharmaceutical K.K. (ヤンセンファーマ株式会社) Original drug not imported to China Approved in Japan The 78th Batch of Reference Listed Drugs
78-28   Risperdal Janssen Pharmaceutical K.K. (ヤンセンファーマ株式会社) Original drug not imported to China Approved in Japan The 78th Batch of Reference Listed Drugs
77-1           / ITALFARMACO SA Original drug approved in China Original drug imported to China The 77th Batch of Reference Listed Drugs
77-2           Carbaglu (卡巴谷) Recordati Rare Diseases Original drug approved in China Original drug imported to China The 77th Batch of Reference Listed Drugs
77-3           / Xinchang Pharmaceutical Factory of Zhejiang Medicine Co., Ltd. Original drug approved in China / The 77th Batch of Reference Listed Drugs
77-4           REZUROCK KADMON PHARMS LLC Original drug not imported to China US Orange Book The 77th Batch of Reference Listed Drugs
77-5           Haldol Janssen Pharmaceuticals, Inc. Original drug not imported to China US Orange Book The 77th Batch of Reference Listed Drugs
77-6           Haldol Janssen Pharmaceuticals, Inc. Original drug not imported to China US Orange Book The 77th Batch of Reference Listed Drugs
77-7           PENNSAID Horizon Therapeutics Ireland DAC Original drug not imported to China US Orange Book The 77th Batch of Reference Listed Drugs
77-8           CAMBIA Assertio Therapeutics Inc Original drug not imported to China US Orange Book The 77th Batch of Reference Listed Drugs